Mack B - Search Results

1

DCE-MRI biomarkers for monitoring an anti-angiogenic triple combination therapy in experimental hypopharynx carcinoma xenografts with immunohistochemical validation.

Sterzik A, Paprottka PM, Zengel P, Hirner H, Roßpunt S, Eschbach R, Moser M, Havla L, Ingrisch M, Mack B, Reiser MF, Nikolaou K, Cyran CC. Sterzik A, et al. Among authors: mack b. Acta Radiol. 2015 Mar;56(3):294-303. doi: 10.1177/0284185114527444. Epub 2014 Mar 7. Acta Radiol. 2015. PMID: 24609871

2

Reducing tumor growth and angiogenesis using a triple therapy measured with Contrast-enhanced ultrasound (CEUS).

Paprottka PM, Roßpunt S, Ingrisch M, Cyran CC, Nikolaou K, Reiser MF, Mack B, Gires O, Clevert DA, Zengel P. Paprottka PM, et al. Among authors: mack b. BMC Cancer. 2015 May 8;15:373. doi: 10.1186/s12885-015-1333-7. BMC Cancer. 2015. PMID: 25947947 Free PMC article.

3

Multimodal therapy for synergic inhibition of tumour cell invasion and tumour-induced angiogenesis.

Zengel P, Ramp D, Mack B, Zahler S, Berghaus A, Muehlenweg B, Gires O, Schmitz S. Zengel P, et al. Among authors: mack b. BMC Cancer. 2010 Mar 11;10:92. doi: 10.1186/1471-2407-10-92. BMC Cancer. 2010. PMID: 20222943 Free PMC article.

4

CD133 is a predictor of poor survival in head and neck squamous cell carcinomas.

Canis M, Lechner A, Mack B, Zengel P, Laubender RP, Koehler U, Heissmeyer V, Gires O. Canis M, et al. Among authors: mack b. Cancer Biomark. 2012;12(2):97-105. doi: 10.3233/CBM-130297. Cancer Biomark. 2012. PMID: 23396254

5

CD133 induces tumour-initiating properties in HEK293 cells.

Canis M, Lechner A, Mack B, Zengel P, Laubender RP, Koehler U, Heissmeyer V, Gires O. Canis M, et al. Among authors: mack b. Tumour Biol. 2013 Feb;34(1):437-43. doi: 10.1007/s13277-012-0568-z. Epub 2012 Nov 13. Tumour Biol. 2013. PMID: 23150174 Free PMC article.

6

Biodistribution of 131I-labeled anti-CK8 monoclonal antibody in HNSCC in xenotransplanted SCID mice.

Andratschke M, Luebbers CW, Johannson V, Schmitt B, Mack B, Zeidler R, Lang S, Wollenberg B, Gildehaus FJ. Andratschke M, et al. Among authors: mack b. Anticancer Res. 2011 Oct;31(10):3315-21. Anticancer Res. 2011. PMID: 21965741

7

CD44s and CD44v6 expression in head and neck epithelia.

Mack B, Gires O. Mack B, et al. PLoS One. 2008;3(10):e3360. doi: 10.1371/journal.pone.0003360. Epub 2008 Oct 9. PLoS One. 2008. PMID: 18852874 Free PMC article.

8

Biodistribution and radioimmunotherapy of SCCHN in xenotransplantated SCID mice with a 131I-labelled anti-EpCAM monoclonal antibody.

Andratschke M, Gildehaus FJ, Johannson V, Schmitt B, Mack B, Reisbach G, Lang S, Lindhofer H, Zeidler R, Wollenberg B, Luebbers CW. Andratschke M, et al. Among authors: mack b. Anticancer Res. 2007 Jan-Feb;27(1A):431-6. Anticancer Res. 2007. PMID: 17352264 Free article.

9

Immune restoration in head and neck cancer patients after in vivo COX-2 inhibition.

Lang S, Tiwari S, Andratschke M, Loehr I, Lauffer L, Bergmann C, Mack B, Lebeau A, Moosmann A, Whiteside TL, Zeidler R. Lang S, et al. Among authors: mack b. Cancer Immunol Immunother. 2007 Oct;56(10):1645-52. doi: 10.1007/s00262-007-0312-5. Epub 2007 Mar 27. Cancer Immunol Immunother. 2007. PMID: 17387473 Free PMC article.

10

Soluble CD44v6 is not a sensitive tumor marker in patients with head and neck squamous cell cancer.

Andratschke M, Chaubal S, Pauli C, Mack B, Hagedorn H, Wollenberg B. Andratschke M, et al. Among authors: mack b. Anticancer Res. 2005 Jul-Aug;25(4):2821-6. Anticancer Res. 2005. PMID: 16080532 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

145 results

Search Page

Filters